*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : RA4550000
CHEMICAL NAME : Nogalamycin
CAS REGISTRY NUMBER : 1404-15-5
LAST UPDATED : 199806
DATA ITEMS CITED : 22
MOLECULAR FORMULA : C39-H49-N-O16
MOLECULAR WEIGHT : 787.89
COMPOUND DESCRIPTOR : Drug
Mutagen
Natural Product
SYNONYMS/TRADE NAMES :
* Antibiotic NSC 70845
* Antibiotic 205T3
* Nogalomycin
* NSC-70845
* U-15167
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ADTEAS Advances in Teratology. (New York, NY) V.1-5, 1966-72.
Discontinued. Volume(issue)/page/year: 3,181,1968
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4600 ug/kg
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
Gastrointestinal - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCIRI* Progress Report Submitted to the National Cancer Insitute by Piason
Research Institute. Volume(issue)/page/year: -,192,1966
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCIRI* Progress Report Submitted to the National Cancer Insitute by Piason
Research Institute. Volume(issue)/page/year: -,192,1966
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 13750 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information
Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-
Volume(issue)/page/year: 17,595,1979
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 8500 ug/kg
TOXIC EFFECTS :
Skin and Appendages - other glands
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCIRI* Progress Report Submitted to the National Cancer Insitute by Piason
Research Institute. Volume(issue)/page/year: -,192,1966
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 250 ug/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Lungs, Thorax, or Respiration - acute pulmonary edema
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
NCIRI* Progress Report Submitted to the National Cancer Insitute by Piason
Research Institute. Volume(issue)/page/year: -,192,1966
** MUTATION DATA **
TYPE OF TEST : DNA damage
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 125 ug
REFERENCE :
ABBIA4 Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.31- 1951- Volume(issue)/page/year:
120,292,1967
TYPE OF TEST : DNA damage
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 125 ug
REFERENCE :
ABBIA4 Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.31- 1951- Volume(issue)/page/year:
120,292,1967
TYPE OF TEST : Phage inhibition capacity
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 120 mg/L
REFERENCE :
ZAPOAK Zeitschrift fuer Allgemeine Mikrobiologie. (Akademie-Verlag GmbH,
Postfach 1233, Berlin DDR-1086 Ger. Dem. Rep.) V.1- 1960-
Volume(issue)/page/year: 8,139,1968
TYPE OF TEST : Phage inhibition capacity
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 250 ng/plate
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
43,2819,1983
TYPE OF TEST : DNA damage
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 125 ug
REFERENCE :
ABBIA4 Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.31- 1951- Volume(issue)/page/year:
120,292,1967
TYPE OF TEST : DNA adduct
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 4 umol/L
REFERENCE :
BBACAQ Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211,
1000 AE Amsterdam, Netherlands) V.1- 1947- Volume(issue)/page/year:
474,199,1977
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 300 mg/L
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for
Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
Volume(issue)/page/year: 19,657,1981
TYPE OF TEST : DNA damage
TEST SYSTEM : Fish - salmon Sperm
DOSE/DURATION : 100 mmol
REFERENCE :
ABBIA4 Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.31- 1951- Volume(issue)/page/year:
120,292,1967
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 410 nmol/L
REFERENCE :
HXPHAU Handbuch der Experimentellen Pharmakologie. (Berlin, Ger.) New
series: V.1-49, 1935-78. For publisher information, see HEPHD2.
Volume(issue)/page/year: 38(Pt 2),623,1975
TYPE OF TEST : DNA damage
TEST SYSTEM : Rodent - mouse Ascites tumor
DOSE/DURATION : 83 umol/L
REFERENCE :
BBACAQ Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211,
1000 AE Amsterdam, Netherlands) V.1- 1947- Volume(issue)/page/year:
374,96,1974
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 2200 nmol/L
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 34,1596,1981
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 320 nmol/L
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 34,1596,1981
TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981
*** REVIEWS ***
TOXICOLOGY REVIEW
CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate
Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year:
2,159,1973
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Nitrosodisulfonic acid, dipotassium salt
| 14293-70-0 |
Nitrosporin
| 1400-54-0 |
Nitrous acid
| 7782-77-6 |
Nitrous acid, butyl ester
| 544-16-1 |
Nitrous acid, sec-butyl ester
| 924-43-6 |
Nitrous acid, t-butyl ester
| 540-80-7 |
Nitrous acid, isobutyl ester
| 542-56-3 |
Nitrous acid, ethyl ester
| 109-95-5 |
Nitrous acid, isopropyl ester
| 541-42-4 |
Nicotinamide, N-(3-(3-indolyl)propyl)-, hydrochloride
| 72612-05-6 |
Nitrous acid, methyl ester
| 624-91-9 |
Nitrous acid, nickel (2+) salt
| 17861-62-0 |
Nitrous acid, pentyl ester
| 463-04-7 |
Nitrous acid, propyl ester
| 543-67-9 |
Nitrous acid, sodium salt
| 7632-00-0 |
Nitroxide, di-tert-butyl
| 2406-25-9 |
NK 154183A
| 152986-47-5 |
NK 154183B
| 152986-49-7 |
NN-105
| 152986-49-7 |
Noboritomycin A
| 68508-45-2 |
Nicotinamide, N-isopentyl-2-(p-methylanilino)-
| 65423-31-6 |
Noboritomycin A, 4-demethyl-4-ethyl-
| 68508-46-3 |
Nocardicin complex
| 76631-42-0 |
Nocardin
| 101975-69-3 |
Nocardorubin
| 1404-14-4 |
NOF-005SUBSTANCE DEFINITION :Chief ingredient of tricaprylinREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-Volume(issue)/page/year: 28,7,1994
| 1404-14-4 |
Nogalamycin
| 1404-15-5 |
Nomate blockaide
| 85800-68-6 |
Nonactin,5,14,23,32-tetrademethyl-5,14,23,32-tetraethyl-
| 33956-61-5 |
2,3-Nonadecanediamine, dihydrochloride, (+-)-
| 33956-61-5 |
1,2,3-Nonadecanetricarboxylic acid, 2-hydroxy-
| 666-99-9 |
Nicotinamide, 2-(p-methoxyanilino)-N-methyl-
| 65423-33-8 |
1,2,3-Nonadecanetricarboxylic acid, 2-hydroxy-,sodium salt
| 78219-78-0 |
10-Nonadecanone, 1,19-difluoro-
| 462-17-9 |
2,10,12,16,18-Nonadecapentanoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl- 6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-
| 87081-35-4 |
2,10,12,16,18-Nonadecapentaenoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-3,5,7,9,11,15,17-heptamethyl-6-hydroxy-8-oxo-
| 87081-36-5 |
5,9,13,17-Nonadecatetraen-2-one,6,10,14,18-tetramethyl-
| 6809-52-5 |
10-Nonadecenamide,N-((4-hydroxy-3-methoxyphenyl)methyl)-, (Z)-
| 95548-11-1 |
2,6-Nonadienal, (E,Z)-
| 557-48-2 |
2,6-Nonadien-1-al, 3,7-dimethyl-
| 41448-29-7 |
2,6-Nonadienenitrile, 3,7-dimethyl-
| 61792-11-8 |
2,6-Nonadienol
| 28069-72-9 |
Nicotinamide,1,4-dihydro-N,1-bis(p-chlorophenyl)-2,6-dimethyl-4-oxo-
| 80357-39-7 |
Nicotinamide, 2-(p-methoxyanilino)-N-propyl-
| 65423-35-0 |
1,6-Nonadien-3-ol, 3,7-dimethyl-
| 10339-55-6 |
1,6-Nonadien-3-ol, 3,7-dimethyl-, acetate
| 61931-80-4 |
5,7-Nonadiyn-4-one, 9-(2-naphthalenyloxy)-
| 52714-38-2 |
1,4-Nonadiyn-3-one, 1-phenyl-
| 50655-45-3 |
Nonaethylene glycol
| 3386-18-3 |
Nonamethylenediamine, N,N'-bis(o-chlorobenzyl)-,dihydrochloride
| 2056-23-7 |
|
|